Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Stephen Waldo

Concepts (407)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Percutaneous Coronary Intervention
75
2025
467
19.330
 Why?
Coronary Artery Disease
45
2025
679
11.150
 Why?
United States Department of Veterans Affairs
30
2025
623
5.210
 Why?
Coronary Angiography
31
2025
306
3.760
 Why?
Peripheral Arterial Disease
25
2020
458
3.440
 Why?
Myocardial Infarction
28
2024
1021
3.430
 Why?
Endovascular Procedures
18
2020
301
3.310
 Why?
Femoral Artery
13
2022
174
2.850
 Why?
Treatment Outcome
90
2025
10219
2.850
 Why?
Veterans
16
2024
1375
2.750
 Why?
Acute Coronary Syndrome
7
2024
267
2.640
 Why?
Vascular Calcification
9
2022
107
2.460
 Why?
Veterans Health
7
2025
177
2.380
 Why?
Stents
21
2019
504
2.350
 Why?
ST Elevation Myocardial Infarction
6
2022
52
2.230
 Why?
Popliteal Artery
11
2020
58
2.210
 Why?
Registries
28
2023
1899
2.110
 Why?
Atherectomy
11
2022
37
2.030
 Why?
Risk Factors
68
2025
9786
2.030
 Why?
Ischemia
11
2020
406
1.850
 Why?
Coronary Artery Bypass
7
2023
224
1.840
 Why?
Time Factors
51
2025
6555
1.810
 Why?
Atherectomy, Coronary
5
2022
10
1.770
 Why?
United States
58
2025
13871
1.750
 Why?
Aged
84
2025
22061
1.740
 Why?
Risk Assessment
28
2025
3262
1.740
 Why?
Time-to-Treatment
5
2024
179
1.650
 Why?
Lower Extremity
4
2018
408
1.630
 Why?
Radial Artery
7
2022
69
1.620
 Why?
Angioplasty, Balloon, Coronary
6
2017
140
1.600
 Why?
Platelet Aggregation Inhibitors
7
2023
443
1.500
 Why?
Middle Aged
79
2025
31136
1.460
 Why?
Hospitals, Veterans
4
2025
243
1.400
 Why?
Cardiovascular Agents
7
2023
157
1.380
 Why?
Humans
154
2025
129625
1.380
 Why?
Non-ST Elevated Myocardial Infarction
3
2020
19
1.350
 Why?
Hospital Mortality
13
2025
848
1.330
 Why?
Biological Products
2
2023
205
1.310
 Why?
Coronary Vessels
7
2025
239
1.240
 Why?
Coronary Restenosis
4
2017
21
1.230
 Why?
Male
97
2025
63670
1.230
 Why?
Angioplasty, Balloon
9
2020
92
1.210
 Why?
Myocardial Revascularization
3
2019
72
1.120
 Why?
Female
91
2025
68734
1.100
 Why?
Access to Information
2
2019
47
1.090
 Why?
Catheterization, Peripheral
2
2019
104
1.080
 Why?
Retrospective Studies
50
2025
14522
1.040
 Why?
Surgical Procedures, Operative
3
2025
244
1.000
 Why?
Myocardial Ischemia
4
2020
259
0.970
 Why?
Angina, Stable
3
2022
17
0.960
 Why?
Patient Readmission
8
2024
653
0.930
 Why?
Eligibility Determination
1
2025
63
0.920
 Why?
Quality Improvement
5
2025
1101
0.920
 Why?
Coated Materials, Biocompatible
6
2020
59
0.910
 Why?
Cardiology
4
2022
266
0.890
 Why?
Myocardial Reperfusion
2
2013
50
0.850
 Why?
Cardiac Catheterization
5
2025
520
0.850
 Why?
Quality of Health Care
2
2019
604
0.840
 Why?
Stroke Volume
3
2021
592
0.820
 Why?
Vascular Patency
14
2020
102
0.810
 Why?
Ventricular Function, Left
3
2021
528
0.800
 Why?
Chickens
1
2023
189
0.800
 Why?
Heart Arrest
3
2017
320
0.790
 Why?
Healthcare Disparities
3
2024
578
0.780
 Why?
Elective Surgical Procedures
2
2020
164
0.770
 Why?
Psoriasis
1
2023
87
0.770
 Why?
Vascular Access Devices
5
2020
26
0.770
 Why?
Coronary Thrombosis
4
2015
24
0.770
 Why?
California
18
2019
400
0.750
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2023
430
0.740
 Why?
Practice Patterns, Physicians'
7
2025
1271
0.740
 Why?
Anemia
2
2022
161
0.730
 Why?
Patient Selection
1
2025
661
0.720
 Why?
Coronary Occlusion
2
2023
18
0.710
 Why?
Heart Failure, Systolic
1
2021
25
0.710
 Why?
Aged, 80 and over
21
2021
7052
0.710
 Why?
Hemorrhage
5
2022
680
0.700
 Why?
Hospitals, Community
1
2020
48
0.680
 Why?
Drug-Eluting Stents
6
2017
74
0.670
 Why?
Paclitaxel
2
2019
217
0.650
 Why?
Assisted Circulation
1
2019
26
0.650
 Why?
Hemostatic Techniques
1
2020
45
0.640
 Why?
Quality Indicators, Health Care
4
2025
298
0.630
 Why?
Databases, Factual
11
2025
1269
0.630
 Why?
Embolic Protection Devices
1
2019
12
0.620
 Why?
Cardiac Surgical Procedures
2
2022
506
0.620
 Why?
Postoperative Hemorrhage
1
2020
87
0.620
 Why?
Intra-Aortic Balloon Pumping
1
2019
17
0.620
 Why?
Saphenous Vein
1
2019
32
0.620
 Why?
Graft Occlusion, Vascular
1
2019
41
0.620
 Why?
Fibrinolytic Agents
2
2018
262
0.600
 Why?
Electrocardiography
4
2015
611
0.600
 Why?
Arterial Occlusive Diseases
1
2018
80
0.580
 Why?
Arm
1
2018
107
0.570
 Why?
Odds Ratio
8
2021
1019
0.570
 Why?
Peripheral Vascular Diseases
1
2018
102
0.560
 Why?
Propensity Score
6
2024
264
0.560
 Why?
Thromboembolism
1
2018
112
0.560
 Why?
Kaplan-Meier Estimate
12
2020
851
0.550
 Why?
Cerebrovascular Disorders
1
2018
90
0.550
 Why?
Limb Salvage
7
2019
57
0.540
 Why?
Postoperative Complications
4
2025
2477
0.540
 Why?
Embolism
1
2017
40
0.530
 Why?
Contrast Media
4
2025
393
0.530
 Why?
Renal Artery Obstruction
1
2017
29
0.530
 Why?
Renal Artery
1
2017
34
0.530
 Why?
Heart Failure
6
2023
2133
0.530
 Why?
Aspirin
2
2019
380
0.530
 Why?
Hospitals
4
2023
637
0.520
 Why?
Research Report
1
2017
76
0.520
 Why?
Catheterization
3
2021
175
0.500
 Why?
Hospitalization
4
2025
2057
0.490
 Why?
Coronary Stenosis
5
2020
39
0.480
 Why?
Iliac Artery
4
2019
55
0.470
 Why?
Hypertension, Pulmonary
5
2025
1894
0.460
 Why?
Risk Reduction Behavior
1
2016
209
0.450
 Why?
Disclosure
1
2015
110
0.440
 Why?
Cohort Studies
10
2023
5426
0.430
 Why?
Thrombectomy
2
2014
58
0.430
 Why?
Cell Separation
1
2015
317
0.430
 Why?
Depressive Disorder
1
2017
367
0.430
 Why?
Atherosclerosis
3
2019
402
0.420
 Why?
Vascular Surgical Procedures
1
2016
295
0.410
 Why?
Cardiologists
2
2025
46
0.400
 Why?
Predictive Value of Tests
9
2025
1947
0.400
 Why?
Disease Management
1
2017
588
0.400
 Why?
Acute Kidney Injury
5
2025
791
0.400
 Why?
Survival Rate
6
2021
1872
0.400
 Why?
Peer Review
2
2025
49
0.380
 Why?
HIV
1
2013
227
0.380
 Why?
Attitude of Health Personnel
1
2019
1098
0.380
 Why?
Logistic Models
6
2017
1986
0.380
 Why?
Intermittent Claudication
3
2017
118
0.370
 Why?
Hypothermia
1
2011
34
0.360
 Why?
Out-of-Hospital Cardiac Arrest
2
2024
70
0.360
 Why?
Incidence
7
2021
2641
0.360
 Why?
Cause of Death
3
2023
395
0.350
 Why?
Mentoring
2
2023
128
0.320
 Why?
Proportional Hazards Models
9
2023
1198
0.320
 Why?
Endothelial Cells
1
2015
749
0.320
 Why?
Mortality
3
2020
307
0.320
 Why?
Constriction, Pathologic
9
2020
234
0.320
 Why?
Peptide Fragments
2
2015
693
0.310
 Why?
Chi-Square Distribution
4
2018
515
0.310
 Why?
Transcatheter Aortic Valve Replacement
2
2021
121
0.300
 Why?
Severity of Illness Index
7
2022
2739
0.300
 Why?
Punctures
2
2019
40
0.300
 Why?
Angiography
6
2020
196
0.290
 Why?
Laser Therapy
2
2019
129
0.290
 Why?
Natriuretic Peptide, Brain
1
2008
99
0.280
 Why?
Carotid Stenosis
2
2018
84
0.270
 Why?
Emergency Medical Services
1
2013
522
0.270
 Why?
Myocardial Perfusion Imaging
2
2019
36
0.270
 Why?
Recurrence
9
2019
1011
0.260
 Why?
HIV Infections
3
2023
2730
0.260
 Why?
Ultrasonography, Interventional
2
2025
128
0.250
 Why?
Ventricular Dysfunction, Left
2
2021
385
0.250
 Why?
Multivariate Analysis
5
2017
1499
0.250
 Why?
Patient Discharge
3
2022
836
0.250
 Why?
Macrophages
3
2008
1488
0.250
 Why?
Acute Disease
3
2017
979
0.240
 Why?
Renal Insufficiency, Chronic
2
2023
566
0.240
 Why?
Purinergic P2Y Receptor Antagonists
2
2023
66
0.240
 Why?
Tomography, Optical Coherence
2
2025
186
0.240
 Why?
Peer Review, Health Care
1
2025
4
0.240
 Why?
Chest Pain
3
2022
88
0.230
 Why?
Chemokine CXCL12
1
2025
79
0.230
 Why?
Follow-Up Studies
6
2021
4894
0.230
 Why?
Comorbidity
5
2020
1547
0.230
 Why?
Pancreas
2
2004
303
0.220
 Why?
Stroke
6
2022
1071
0.220
 Why?
Sex Factors
4
2024
1970
0.220
 Why?
Prosthesis Failure
2
2016
114
0.220
 Why?
Hypothermia, Induced
1
2024
76
0.210
 Why?
Hypertension, Portal
1
2024
61
0.210
 Why?
Cross-Sectional Studies
6
2022
5075
0.210
 Why?
Coronary Circulation
2
2014
138
0.210
 Why?
Fractional Flow Reserve, Myocardial
2
2020
8
0.200
 Why?
Biological Therapy
1
2023
28
0.200
 Why?
Prognosis
6
2021
3774
0.200
 Why?
New York
3
2017
128
0.200
 Why?
Work Engagement
1
2022
10
0.190
 Why?
Clinical Decision-Making
1
2025
301
0.190
 Why?
Chronic Disease
5
2023
1720
0.190
 Why?
Leukocytes
1
2003
306
0.190
 Why?
Critical Illness
8
2020
758
0.190
 Why?
Technology Transfer
1
2021
10
0.190
 Why?
Hemodynamics
4
2024
1090
0.180
 Why?
Social Class
1
2023
259
0.180
 Why?
Anticoagulants
2
2016
637
0.170
 Why?
Shock, Cardiogenic
2
2021
60
0.170
 Why?
Angina Pectoris
1
2020
67
0.170
 Why?
Aftercare
1
2022
203
0.170
 Why?
Mandatory Reporting
2
2017
45
0.170
 Why?
Patient Care Team
1
2025
600
0.170
 Why?
Thrombocytopenia
1
2022
186
0.170
 Why?
Exercise Test
2
2022
613
0.160
 Why?
Massachusetts
2
2017
159
0.160
 Why?
Genome-Wide Association Study
2
2025
1326
0.160
 Why?
Echocardiography, Stress
1
2019
20
0.160
 Why?
Delivery of Health Care
2
2023
898
0.160
 Why?
Health Facilities
1
2019
80
0.160
 Why?
Fluid Therapy
1
2020
133
0.160
 Why?
Ambulatory Surgical Procedures
1
2019
58
0.160
 Why?
Intraoperative Period
1
2019
53
0.150
 Why?
Socioeconomic Factors
1
2023
1213
0.150
 Why?
Vascular Resistance
1
2020
371
0.150
 Why?
Heart
1
2022
641
0.150
 Why?
Centralized Hospital Services
1
2018
6
0.150
 Why?
Thrombosis
1
2022
348
0.150
 Why?
Perioperative Care
1
2020
151
0.150
 Why?
Secondary Prevention
1
2019
219
0.150
 Why?
Colorado
8
2019
4404
0.150
 Why?
Perception
1
2021
344
0.150
 Why?
Biomarkers
4
2017
3968
0.150
 Why?
Angioplasty, Balloon, Laser-Assisted
1
2017
1
0.150
 Why?
Disease-Free Survival
5
2017
646
0.150
 Why?
Transportation of Patients
1
2018
50
0.150
 Why?
Angioplasty
1
2018
47
0.140
 Why?
Pregnancy-Associated Plasma Protein-A
1
2017
14
0.140
 Why?
Diabetes Mellitus, Type 2
2
2023
2442
0.140
 Why?
Cardiac Catheters
1
2017
15
0.140
 Why?
Algorithms
2
2017
1616
0.140
 Why?
Rosuvastatin Calcium
1
2017
20
0.140
 Why?
Clinical Competence
1
2025
1017
0.140
 Why?
ADAMTS13 Protein
1
2017
6
0.140
 Why?
Macrophage Colony-Stimulating Factor
2
2008
17
0.140
 Why?
Computer Simulation
1
2021
939
0.140
 Why?
Pulmonary Artery
1
2023
1097
0.140
 Why?
Neck
1
2017
95
0.140
 Why?
Thrombotic Microangiopathies
1
2017
15
0.140
 Why?
Ankle Brachial Index
1
2017
36
0.140
 Why?
Reproducibility of Results
5
2025
3080
0.130
 Why?
Risk
2
2019
855
0.130
 Why?
Suction
2
2014
32
0.130
 Why?
Policy Making
1
2017
88
0.130
 Why?
Adult
7
2024
35599
0.130
 Why?
Aortic Valve Stenosis
1
2019
218
0.130
 Why?
Cardiovascular Diseases
2
2020
2006
0.130
 Why?
Flow Cytometry
2
2015
1159
0.130
 Why?
Aortic Valve
1
2019
347
0.130
 Why?
Health Services Needs and Demand
1
2018
263
0.130
 Why?
Academic Medical Centers
2
2016
475
0.130
 Why?
Boston
1
2016
89
0.130
 Why?
Burnout, Professional
1
2022
405
0.120
 Why?
Pandemics
2
2021
1491
0.120
 Why?
Dyslipidemias
1
2017
177
0.120
 Why?
Delivery of Health Care, Integrated
1
2018
248
0.120
 Why?
Cholesterol
2
2008
412
0.120
 Why?
Receptors, Cytoplasmic and Nuclear
2
2007
217
0.120
 Why?
Gene Expression Profiling
2
2015
1687
0.120
 Why?
Contraindications
1
2014
90
0.120
 Why?
Antithrombins
1
2015
58
0.120
 Why?
Aortic Diseases
1
2016
113
0.110
 Why?
Collateral Circulation
1
2014
18
0.110
 Why?
Models, Cardiovascular
1
2015
191
0.110
 Why?
Prevalence
2
2019
2564
0.110
 Why?
Prospective Studies
3
2020
7135
0.110
 Why?
Observer Variation
3
2025
314
0.110
 Why?
Heparin
1
2015
254
0.100
 Why?
Resuscitation
1
2015
237
0.100
 Why?
Diabetes Mellitus
2
2018
1001
0.100
 Why?
Incidental Findings
1
2013
80
0.100
 Why?
Primary Prevention
1
2014
190
0.100
 Why?
Smoking Cessation
1
2016
408
0.100
 Why?
Coronary Disease
1
2014
385
0.100
 Why?
Electronic Health Records
2
2017
973
0.100
 Why?
Trazodone
1
2011
2
0.090
 Why?
Antimanic Agents
1
2011
18
0.090
 Why?
Lithium
1
2011
37
0.090
 Why?
Glucagon-Like Peptide-1 Receptor
2
2023
92
0.090
 Why?
Triazines
1
2011
38
0.090
 Why?
Health Services Accessibility
1
2018
903
0.090
 Why?
Laboratories
2
2022
108
0.090
 Why?
American Heart Association
2
2022
300
0.090
 Why?
Prosthesis Design
3
2017
309
0.090
 Why?
Decision Support Techniques
1
2014
398
0.090
 Why?
Benzodiazepines
1
2011
134
0.090
 Why?
Anticonvulsants
1
2011
209
0.080
 Why?
Cell Differentiation
2
2008
1891
0.080
 Why?
Age Factors
4
2019
3152
0.080
 Why?
Lipoproteins, LDL
2
2007
127
0.080
 Why?
Depression
1
2018
1317
0.080
 Why?
Bipolar Disorder
1
2011
235
0.080
 Why?
MicroRNAs
1
2015
679
0.070
 Why?
Seizures
1
2011
401
0.070
 Why?
Animals
4
2025
35391
0.070
 Why?
Pinocytosis
1
2007
10
0.070
 Why?
Area Under Curve
1
2008
304
0.070
 Why?
Ultrasonography, Doppler, Duplex
2
2017
43
0.070
 Why?
Monocytes
2
2007
553
0.070
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2008
147
0.070
 Why?
Fluorescent Antibody Technique
1
2008
376
0.070
 Why?
Drug Overdose
1
2011
322
0.070
 Why?
Phenotype
2
2021
3075
0.070
 Why?
ROC Curve
1
2008
503
0.070
 Why?
Inflammation
3
2008
2750
0.060
 Why?
Adrenergic beta-Antagonists
2
2019
321
0.060
 Why?
Polymorphism, Single Nucleotide
2
2025
2060
0.060
 Why?
Shock
2
2004
92
0.060
 Why?
Equipment Design
2
2018
514
0.060
 Why?
Polymerase Chain Reaction
1
2008
1035
0.060
 Why?
Exercise
1
2016
1928
0.060
 Why?
Program Evaluation
2
2019
875
0.060
 Why?
Lipid Metabolism
1
2008
503
0.060
 Why?
Survival Analysis
2
2020
1269
0.060
 Why?
Ventricular Fibrillation
1
2024
57
0.060
 Why?
Trypsin
1
2004
74
0.060
 Why?
Length of Stay
2
2019
1122
0.050
 Why?
Matrix Metalloproteinase 9
1
2004
119
0.050
 Why?
Amylases
1
2003
17
0.050
 Why?
Chymotrypsin
1
2003
19
0.050
 Why?
Ezetimibe
1
2023
25
0.050
 Why?
Hypoglycemic Agents
2
2023
1221
0.050
 Why?
Tissue Distribution
1
2003
315
0.050
 Why?
Tachycardia, Ventricular
1
2024
168
0.050
 Why?
Glucagon-Like Peptide 1
1
2023
114
0.050
 Why?
Drug Therapy, Combination
2
2016
1042
0.050
 Why?
Pancreatitis
1
2003
129
0.050
 Why?
Rats, Wistar
1
2003
442
0.050
 Why?
Practice Guidelines as Topic
2
2020
1501
0.050
 Why?
Personnel Turnover
1
2022
39
0.050
 Why?
Liver Cirrhosis
1
2024
281
0.050
 Why?
Cell Death
1
2003
354
0.050
 Why?
Reperfusion Injury
1
2004
272
0.050
 Why?
Cholesterol, LDL
1
2023
358
0.050
 Why?
Ambulatory Care
1
2025
506
0.040
 Why?
Neutrophils
2
2004
1210
0.040
 Why?
Troponin
1
2021
50
0.040
 Why?
Organizational Culture
1
2022
138
0.040
 Why?
Disease Progression
2
2019
2627
0.040
 Why?
Inpatients
1
2025
475
0.040
 Why?
Systole
1
2021
191
0.040
 Why?
Cells, Cultured
1
2008
4084
0.040
 Why?
Free Radical Scavengers
1
2020
82
0.040
 Why?
Sodium Bicarbonate
1
2020
37
0.040
 Why?
Job Satisfaction
1
2022
201
0.040
 Why?
DNA-Binding Proteins
1
2007
1445
0.040
 Why?
Cytokines
1
2008
2021
0.040
 Why?
Consensus
1
2023
618
0.040
 Why?
Sodium
1
2020
205
0.040
 Why?
Hospitals, High-Volume
1
2019
39
0.040
 Why?
Acetylcysteine
1
2020
146
0.040
 Why?
Exercise Tolerance
1
2021
273
0.040
 Why?
Cost Savings
1
2019
78
0.040
 Why?
Angiotensin Receptor Antagonists
1
2019
89
0.040
 Why?
Endocrinologists
1
2018
12
0.040
 Why?
Retreatment
1
2018
70
0.040
 Why?
Drug Utilization
1
2019
171
0.040
 Why?
Comparative Effectiveness Research
1
2019
150
0.040
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2019
198
0.040
 Why?
Hypertension
2
2018
1243
0.040
 Why?
Rats
2
2004
5483
0.040
 Why?
Transcription Factors
1
2006
1647
0.040
 Why?
Republic of Korea
1
2017
29
0.040
 Why?
Singapore
1
2017
20
0.040
 Why?
Angina, Unstable
1
2017
76
0.030
 Why?
Purpura, Thrombotic Thrombocytopenic
1
2017
12
0.030
 Why?
Combined Modality Therapy
1
2020
1203
0.030
 Why?
New Jersey
1
2016
12
0.030
 Why?
Michigan
1
2016
104
0.030
 Why?
Glomerular Filtration Rate
1
2020
712
0.030
 Why?
Aortography
1
2016
51
0.030
 Why?
Postoperative Care
1
2017
241
0.030
 Why?
Platelet Aggregation
1
2016
96
0.030
 Why?
Guideline Adherence
1
2019
527
0.030
 Why?
Drug Prescriptions
1
2017
248
0.030
 Why?
Glucose
1
2020
1002
0.030
 Why?
Blood Transfusion
1
2017
295
0.030
 Why?
Linear Models
1
2017
819
0.030
 Why?
Hirudins
1
2015
53
0.030
 Why?
Blood Coagulation
1
2016
239
0.030
 Why?
Clinical Trials as Topic
1
2019
1005
0.030
 Why?
Protective Factors
1
2014
91
0.030
 Why?
Genetic Predisposition to Disease
1
2022
2274
0.030
 Why?
Lipids
1
2017
627
0.030
 Why?
Health Policy
1
2016
353
0.030
 Why?
Emergencies
1
2013
156
0.020
 Why?
Blood Flow Velocity
1
2014
406
0.020
 Why?
Recombinant Proteins
1
2015
1308
0.020
 Why?
Cost-Benefit Analysis
1
2014
569
0.020
 Why?
Health Care Costs
1
2014
367
0.020
 Why?
Kidney Failure, Chronic
1
2017
546
0.020
 Why?
Longitudinal Studies
1
2018
2720
0.020
 Why?
Models, Biological
1
2017
1724
0.020
 Why?
Surveys and Questionnaires
1
2022
5415
0.020
 Why?
Medicare
1
2014
708
0.020
 Why?
Mice
1
2025
16961
0.020
 Why?
Clofibrate
1
2007
4
0.020
 Why?
Orphan Nuclear Receptors
1
2007
15
0.020
 Why?
Peroxisome Proliferator-Activated Receptors
1
2007
15
0.020
 Why?
Hydrocarbons, Fluorinated
1
2007
9
0.020
 Why?
Liver X Receptors
1
2007
31
0.020
 Why?
beta-Cyclodextrins
1
2007
27
0.020
 Why?
Down-Regulation
1
2007
636
0.010
 Why?
Physicians
1
2013
866
0.010
 Why?
Telemedicine
1
2013
792
0.010
 Why?
Mesenteric Arteries
1
2004
17
0.010
 Why?
Jejunum
1
2004
30
0.010
 Why?
Interleukin-10
1
2006
300
0.010
 Why?
Gelatin
1
2004
42
0.010
 Why?
Peroxidase
1
2004
175
0.010
 Why?
Sulfonamides
1
2007
497
0.010
 Why?
Microscopy, Fluorescence
1
2004
399
0.010
 Why?
Enzyme Activation
1
2004
813
0.010
 Why?
Blotting, Western
1
2004
1206
0.010
 Why?
Rats, Sprague-Dawley
1
2004
2395
0.010
 Why?
Waldo's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (407) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)